Taiwan Liposome Company, Ltd. Aktie Nasdaq
Aktien
A2N9ZC
US8740381020
TLC
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Chih Hung Yeh
CEO | Chief Executive Officer | 52 | 01.03.02 |
Kee Lung Hong
CHM | Chairman | 81 | 10.11.97 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Mao Jung Lin
BRD | Director/Board Member | 69 | 31.05.17 |
Kee Lung Hong
CHM | Chairman | 81 | 10.11.97 |
Chih Hung Yeh
CEO | Chief Executive Officer | 52 | 01.03.02 |
% 1. Jan. | Kap. | |
---|---|---|
+20.20% | 127 Mrd. | |
+24.53% | 117 Mrd. | |
+25.44% | 27.67 Mrd. | |
-17.75% | 20.33 Mrd. | |
-15.17% | 16.79 Mrd. | |
-14.26% | 15.63 Mrd. | |
+12.18% | 14.84 Mrd. | |
-47.10% | 14.65 Mrd. | |
+56.07% | 14.43 Mrd. |